Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Sultan

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Thrombosis and Haemostasis|December 29, 1984
An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodies-comparison with polyclonal rabbit antibodies for use in von Willebrand's disease diagnosisY Sultan, P Avner, P Maisonneuve, et al.
Journal of Tropical Pediatrics|December 1, 1995
Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi SepticaemiaN I Girgis, D R Tribble, Y Sultan, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1973
[Measurement of platelet factor 3 during central thrombocytopenia]Y Sultan, M L Scrobohaci, N Jaillet, et al.
Developments in Biological Standardization|January 1, 1984
Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patientsP Avner, D Arnaud, Y Sultan, et al.
Lancet (London, England)|October 6, 1984
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulinY Sultan, M D Kazatchkine, P Maisonneuve, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|May 18, 1981
[Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor]B Sola, P Avner, Y Sultan, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Variable (V) region-mediated control of autoreactivity to factor VIIIM D Kazatchkine, S S Kaveri, U E Nydegger, et al.
Histochemistry|January 1, 1990
Tissue-plasminogen activator RNA detected in megakaryocytes by in situ hybridization and biotinylated probeC Brisson-Jeanneau, L Nelles, E Rouer, et al.
Emergency Medicine Journal : EMJ|June 23, 2004
Application of the Canadian CT head rules in managing minor head injuries in a UK emergency department: implications for the implementation of the NICE guidelinesH Y Sultan, A Boyle, M Pereira, et al.
Seminars in Hematology|April 1, 1994
The use of intravenous immunoglobulins in the treatment of factor VIII inhibitorsY Sultan, M D Kazatchkine, M Algiman, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Thrombosis and Haemostasis|December 29, 1984
An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodies-comparison with polyclonal rabbit antibodies for use in von Willebrand's disease diagnosisY Sultan, P Avner, P Maisonneuve, et al.
Journal of Tropical Pediatrics|December 1, 1995
Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi SepticaemiaN I Girgis, D R Tribble, Y Sultan, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1973
[Measurement of platelet factor 3 during central thrombocytopenia]Y Sultan, M L Scrobohaci, N Jaillet, et al.
Developments in Biological Standardization|January 1, 1984
Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patientsP Avner, D Arnaud, Y Sultan, et al.
Lancet (London, England)|October 6, 1984
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulinY Sultan, M D Kazatchkine, P Maisonneuve, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|May 18, 1981
[Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor]B Sola, P Avner, Y Sultan, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Variable (V) region-mediated control of autoreactivity to factor VIIIM D Kazatchkine, S S Kaveri, U E Nydegger, et al.
Histochemistry|January 1, 1990
Tissue-plasminogen activator RNA detected in megakaryocytes by in situ hybridization and biotinylated probeC Brisson-Jeanneau, L Nelles, E Rouer, et al.
Emergency Medicine Journal : EMJ|June 23, 2004
Application of the Canadian CT head rules in managing minor head injuries in a UK emergency department: implications for the implementation of the NICE guidelinesH Y Sultan, A Boyle, M Pereira, et al.
Seminars in Hematology|April 1, 1994
The use of intravenous immunoglobulins in the treatment of factor VIII inhibitorsY Sultan, M D Kazatchkine, M Algiman, et al.
Pageof 19